KalVista Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD for Q2 2019

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
KalVista Pharmaceuticals, Inc. annual/quarterly Operating Lease, Payments history and growth rate for Q2 2019.
  • KalVista Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending July 31, 2019 was $175K.
  • KalVista Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $1.68M, a 4.21% increase from 2022.
  • KalVista Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $1.62M, a 25.5% increase from 2021.
  • KalVista Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $1.29M, a 84.9% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2019 $175K May 1, 2019 Jul 31, 2019 10-Q 2019-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.